- A comparison of the long-term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe: a EuroSIDA study2011 | Lékařská fakulta v Plzni, 3. lékařská fakulta
- Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA2019 | Lékařská fakulta v Plzni
- HIV resistance testing and detected drug resistance in Europe2015 | 3. lékařská fakulta
- Influence of hepatitis C virus co-infection and hepatitis C virus treatment on risk of chronic kidney disease in HIV-positive persons2020 | Lékařská fakulta v Plzni
- Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy2011 | 3. lékařská fakulta
- The role of HIV/hepatitis B virus/hepatitis C virus RNA plus triple infection in end-stage liver disease and all-cause mortality in Europe2023 | Publikace bez příslušnosti k fakultě
- Antiretrovirals, Fractures, and Osteonecrosis in a Large International HIV Cohort2017 | Lékařská fakulta v Plzni
- Immuno-Virological Discordance and the Risk of Non-AIDS and AIDS Events in a Large Observational Cohort of HIV-Patients in Europe2014 | 3. lékařská fakulta
- Long-term effectiveness of recommended boosted protease inhibitor-based antiretroviral therapy in Europe2018 | Lékařská fakulta v Plzni
- The extent of B-cell activation and dysfunction preceding lymphoma development in HIV-positive people2018 | 1. lékařská fakulta
- Where is the greatest impact of uncontrolled HIV infection on AIDS and non-AIDS events in HIV?2018 | Lékařská fakulta v Plzni
- Liver-related death among HIV/hepatitis C virus-co-infected individuals: Implications for the era of directly acting antivirals2015 | Lékařská fakulta v Plzni
- Plasma HIV-1 Tropism and the Risk of Short-Term Clinical Progression to AIDS or Death2017 | Lékařská fakulta v Plzni
- Variation in antiretroviral treatment coverage and virological suppression among three HIV key populations2018 | Lékařská fakulta v Plzni
- Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens2018 | 3. lékařská fakulta, 1. lékařská fakulta
- Hepatitis delta infection among persons living with HIV in EuropePublikace bez příslušnosti k fakultě